| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ZIOPHARM ONCOLOGY INC | 12,062,803 | 144,754,000 | 51.72% | ||
| 2 | INTREXON CORP | 2,100,085 | 102,484,000 | 36.62% | ||
| 3 | WILLIAMS PARTNERS L P NEW | 172,732 | 8,365,000 | 2.99% | ||
| 4 | BIO PATH HOLDINGS INC | 3,830,882 | 4,406,000 | 1.57% | ||
| 5 | VANGUARD INDEX FDS | 16,421 | 3,101,000 | 1.11% | ||
| 6 | VANGUARD TAX-MANAGED FDS | 65,204 | 2,585,000 | 0.92% | ||
| 7 | VANGUARD INTL EQUITY INDEX F | 60,541 | 2,475,000 | 0.88% | ||
| 8 | VANGUARD INDEX FDS | 26,234 | 2,376,000 | 0.85% | ||
| 9 | GENERAL MOLY | 2,922,831 | 2,069,000 | 0.74% | ||
| 10 | VANGUARD WORLD FD | 17,039 | 1,822,000 | 0.65% | ||
| 11 | SPDR GOLD TR | 15,361 | 1,726,000 | 0.62% | ||
| 12 | TEXAS INSTRS INC | 32,000 | 1,648,000 | 0.59% | ||
| 13 | VANGUARD INDEX FDS | 18,431 | 1,377,000 | 0.49% | ||
| 14 | LEXICON PHARMACEUTICALS | 35,714 | 287,000 | 0.10% | ||
| 15 | MOBILEYE N V AMSTELVEEN | 3,900 | 207,000 | 0.07% | ||
| 16 | INVESCO LTD | 5,000 | 187,000 | 0.07% | ||
| 17 | PORTLAND GEN ELEC CO | 118 | 4,000 | 0.00% | ||
| 18 | EQUIFAX INC | 29 | 3,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019231-15-000015, filed 2015.08.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
